Since its first description by H.G. Creutzfeldt and A.Jakob, six forms
of human spongiform encephalopathies have been described. Besides Cre
utzfeldt-Jakob disease (CJD), a new variant CJD (nvCJD), Gerstmann-Str
aussler Scheinker syndrome (GSS), fatal familial insomnia (FFI) and po
tentially familial progressive subcortical gliosis have been reported.
The most likely causative agent of these and at least six animal-tran
smissible spongiform encephalopathies (TSE) is a structurally altered
form of a regular cellular protein, designated prion. The best known a
nimal forms are bovine spongiform encephalopathy (BSE) and scrapie. Th
e clinical spectrum of human spongiform encephalopathies has been expa
nded in recent years by the discovery of new, partially genetically de
termined forms. The currently available clinical, neurophysiological,
neuroradiological, biochemical and molecular-biological methods permit
only a probable diagnosis of CJD. A definite diagnosis can only be ac
hieved by the neuropathological demonstration of the pathological prio
n protein (PrPSc). The transmission of BSE to humans has neither been
shown nor definitely excluded.